Onsdag 28 Oktober | 21:00:32 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

Strax - Low Valuation with Two Triggers

2021-05-31 07:51:00

Sales in Q1 was higher than we expected due to strong sales in primarily Health & Wellness, but also in accessories and audio. Health & wellness and online sales contributed to a low gross margin, which resulted in a weaker than expected EBITDA. Covid is a waiting game for Strax and we believe the low valuation in combination with two triggers create a good opportunity. We maintain our valuation.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/